azacitidine,lemzoparlimab
abbvie,i-mab
['azacitidine,(-oral azaci),(-azacitidine oral)', 'lemzoparlimab', '$imab']
i-mab announces positive phase 2 data of lemzoparlimab in combination with azacitidine (aza) in patients with higher risk myelodysplastic syndrome at esmo 2022 -- pr newswire. $imab